LSWWX
Price
$25.26
Change
-$0.37 (-1.44%)
Updated
Feb 21 closing price
Net Assets
2.93B
RIRBX
Price
$72.48
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
Ad is loading...

LSWWX vs RIRBX

Header iconLSWWX vs RIRBX Comparison
Open Charts LSWWX vs RIRBXBanner chart's image
Loomis Sayles Global Allocation Y
Price$25.26
Change-$0.37 (-1.44%)
VolumeN/A
Net Assets2.93B
American Funds Capital Income Bldr R2
Price$72.48
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
LSWWX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSWWX vs. RIRBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSWWX is a StrongBuy and RIRBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 110B vs. LSWWX (2.93B). RIRBX pays higher dividends than LSWWX: RIRBX (2.55) vs LSWWX (0.35). LSWWX was incepted earlier than RIRBX: LSWWX (29 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. LSWWX (19.00). RIRBX has a lower initial minimum investment than LSWWX: RIRBX (250) vs LSWWX (100000). RIRBX annual gain was more profitable for investors over the last year : 11.30 vs. LSWWX (4.43). RIRBX return over 5 years is better than : 24.48 vs. LSWWX (2.55).
LSWWXRIRBXLSWWX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years23 years-
Gain YTD2.9344.98359%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.93B110B3%
Annual Yield % from dividends0.352.5514%
Returns for 1 year4.4311.3039%
Returns for 3 years2.1611.9318%
Returns for 5 years2.5524.4810%
Returns for 10 years35.4031.54112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KELYA13.870.18
+1.31%
Kelly Services
LRMR3.19-0.08
-2.45%
Larimar Therapeutics
EXPE196.81-8.33
-4.06%
Expedia Group
OSIS202.27-12.10
-5.64%
OSI Systems
SABS1.82-0.13
-6.67%
SAB Biotherapeutics